ArsenalBio

Xyphos Biosciences Inc., located in South San Francisco, is dedicated to developing flexible and controllable immune cell therapies aimed at transforming cancer treatment for patients. The company focuses on achieving safety, efficacy, and versatility in its next-generation cancer immunotherapy solutions. With a commitment to innovation, Xyphos strives to deliver adaptable cancer therapies that have the potential to revolutionize cancer care. The company's efforts are supported through its partnerships, including collaboration with Astellas. Generated from the website

Toreador Therapeutics, founded in 2020 and based in San Francisco, CA, is dedicated to revolutionizing cancer therapeutics with a mission to develop safer and more effective medications for cancer patients. The company is led by experienced entrepreneurs and drug developers committed to advancing treatments in the oncology field. With a focus on innovation, Toreador emphasizes the importance of professional medical advice, ensuring that all information regarding medical conditions and treatments provided by the company is for educational purposes only. Their efforts are underscored by a commitment to intellectual property protection and responsible use of their proprietary content. Generated from the website

The Parker Institute for Cancer Immunotherapy in San Francisco, CA is dedicated to accelerating the development of breakthrough immune therapies to transform all cancers into curable diseases. Through strategic partnerships with academic collaborators, pharma, biotech, and nonprofit organizations, they focus on pioneering research and inventions in cancer immunotherapy. With a mission to develop breakthrough immune therapies, the Parker Institute for Cancer Immunotherapy aims to turn all cancers into curable diseases faster. Led by a team of dedicated staff and renowned thinkers, they work towards their vision of revolutionizing cancer treatment and improving patient outcomes.Generated from the website